Joshua Jones

Joshua Jones has extensive work experience in the biopharmaceutical industry. Joshua is currently working as the Director of Clinical Development at Adela, Inc., where they collaborate with academic key opinion leaders to accelerate the clinical validation of pipeline products and designs development plans for target product profiles. Prior to this, Joshua served as the Director of Clinical Science at Epic Sciences, where they contributed to the company's research efforts. Joshua also worked at Myriad Genetics as a Manager of Business Development and Product Development Manager, involved in partnership development and clinical utility definition for companion diagnostic products. Joshua's earlier roles include Associate Director and Manager of Business Development at Myrexis, Inc., where they directed initiatives related to therapeutic product development, and Clinical Affairs Analyst and Scientist at Myriad Pharmaceuticals, where they evaluated potential in-licensing opportunities and implemented imaging technologies. Joshua's education includes a graduate degree from Stanford University and research experience at Duke University Medical Center.

Joshua Jones earned a PhD in Molecular Pharmacology from Stanford University School of Medicine, where they studied from 1999 to 2004. Prior to that, from 1990 to 1994, they obtained a BA cum laude in Biochemistry from the University of Colorado Boulder.